{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T08:03:08Z","timestamp":1789632188620,"version":"build-2803163510"},"reference-count":28,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15803","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T11:05:23Z","timestamp":1785927923000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Emergence of KRAS mosaicism with multiple variants during treatment with alectinib in ALK\u2011positive metastatic non\u2011small cell lung cancer: A case report"],"prefix":"10.3892","volume":"32","author":[{"given":"Aliz\u00e9e","family":"Simon","sequence":"first","affiliation":[{"name":"University of Lille, Inserm (French National Institute of Health and Medical Research), Lille Regional University Hospital Center, French National Centre for Scientific Research, Oscar Lambret Center, Joint Research Unit 9020\u2011CANTHER\u2011Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000 Lille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautier","family":"Treffel","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Medicine, Nancy Regional University Hospital, 54511 Vand\u0153uvre\u2011l\u00e8s\u2011Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Pax","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Lorraine Institute of Cancerology\/Nancy Regional University Hospital, 54519 Vand\u0153uvre\u2011l\u00e8s\u2011Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Gauchotte","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Lorraine Institute of Cancerology\/Nancy Regional University Hospital, 54519 Vand\u0153uvre\u2011l\u00e8s\u2011Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Husson","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Lorraine Institute of Cancerology\/Nancy Regional University Hospital, 54519 Vand\u0153uvre\u2011l\u00e8s\u2011Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Idrissia","family":"Hanriot","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Lorraine Institute of Cancerology\/Nancy Regional University Hospital, 54519 Vand\u0153uvre\u2011l\u00e8s\u2011Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Leroux","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Lorraine Institute of Cancerology\/Nancy Regional University Hospital, 54519 Vand\u0153uvre\u2011l\u00e8s\u2011Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Merlin","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Lorraine Institute of Cancerology\/Nancy Regional University Hospital, 54519 Vand\u0153uvre\u2011l\u00e8s\u2011Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Harl\u00e9","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Lorraine Institute of Cancerology\/Nancy Regional University Hospital, 54519 Vand\u0153uvre\u2011l\u00e8s\u2011Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Gilson","sequence":"additional","affiliation":[{"name":"Department of Biopathology, Lorraine Institute of Cancerology\/Nancy Regional University Hospital, 54519 Vand\u0153uvre\u2011l\u00e8s\u2011Nancy, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"key":"key20260917101225_b1-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"e0117333","DOI":"10.1371\/journal.pone.0117333","article-title":"Clinicopathological characteristics of patients with non-small-cell lung cancer who harbor EML4-ALK fusion gene: A meta-analysis","volume":"10","author":"Zhao","year":"2015","journal-title":"PLoS One"},{"key":"key20260917101225_b2-ol-32-4-15803","first-page":"100015","article-title":"Catalog of 5\u2032 fusion partners in ALK-positive NSCLC circa 2020","volume":"1","author":"Ou","year":"2020","journal-title":"JTO Clin Res Rep"},{"key":"key20260917101225_b3-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.lungcan.2020.09.012","article-title":"Distribution of EML4-ALK fusion variants and clinical outcomes in patients with resected non-small cell lung cancer","volume":"149","author":"Tao","year":"2020","journal-title":"Lung Cancer"},{"key":"key20260917101225_b4-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","article-title":"Oncogene-addicted metastatic non-small-cell lung cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"34","author":"Hendriks","year":"2023","journal-title":"Ann Oncol"},{"key":"key20260917101225_b5-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00408-025-00801-x","article-title":"Update 2025: Management of non-small-cell lung cancer","volume":"203","author":"Jeon","year":"2025","journal-title":"Lung"},{"key":"key20260917101225_b6-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.annonc.2020.04.478","article-title":"Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study","volume":"31","author":"Mok","year":"2020","journal-title":"Ann Oncol"},{"key":"key20260917101225_b7-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA8503","article-title":"Lorlatinib versus crizotinib in patients with advanced ALK-positive non-small cell lung cancer: 5-year outcomes from the phase III CROWN study","volume":"42","author":"Solomon","year":"2024","journal-title":"J Clin Oncol"},{"key":"key20260917101225_b8-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"S265","DOI":"10.21037\/tlcr.2019.09.15","article-title":"Role of liquid biopsy in oncogene-addicted non-small cell lung cancer","volume":"8","author":"Canale","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"key20260917101225_b9-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"16386","DOI":"10.1038\/s41598-020-73421-5","article-title":"Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers","volume":"10","author":"Gilson","year":"2020","journal-title":"Sci Rep"},{"key":"key20260917101225_b10-ol-32-4-15803","article-title":"French national guidelines for molecular testing and precision medicine in thoracic oncology","author":"Institut Francophone de Canc\u00e9rologie Thoracique (IFCT)","year":"2023"},{"key":"key20260917101225_b11-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1158\/2159-8290.CD-16-0596","article-title":"Molecular mechanisms of resistance to first- and second-generation ALK inhibitors in ALK-rearranged lung cancer","volume":"6","author":"Gainor","year":"2016","journal-title":"Cancer Discov"},{"key":"key20260917101225_b12-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"e77","DOI":"10.1016\/j.cllc.2016.03.005","article-title":"Anaplastic lymphoma kinase (ALK) kinase domain mutation following ALK inhibitor(s) failure in advanced ALK positive non-small-cell lung cancer: Analysis and literature review","volume":"17","author":"Lin","year":"2016","journal-title":"Clin Lung Cancer"},{"key":"key20260917101225_b13-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1159\/000430852","article-title":"Updated evidence on the mechanisms of resistance to ALK inhibitors and strategies to overcome such resistance: Clinical and preclinical data","volume":"38","author":"Toyokawa","year":"2015","journal-title":"Oncol Res Treat"},{"key":"key20260917101225_b14-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1158\/1078-0432.CCR-11-2906","article-title":"Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small cell lung cancer","volume":"18","author":"Doebele","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20260917101225_b15-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/1756-0500-6-489","article-title":"Concomitant occurrence of EGFR (epidermal growth factor receptor) and KRAS (V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog) mutations in an ALK (anaplastic lymphoma kinase)-positive lung adenocarcinoma patient with acquired resistance to crizotinib: A case report","volume":"6","author":"Rossing","year":"2013","journal-title":"BMC Res Notes"},{"key":"key20260917101225_b16-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.5301\/jbm.5000127","article-title":"Lung adenocarcinoma with concurrent KRAS mutation and ALK rearrangement responding to crizotinib: Case report","volume":"30","author":"Campos-Gomez","year":"2015","journal-title":"Int J Biol Markers"},{"key":"key20260917101225_b17-ol-32-4-15803","first-page":"3007","article-title":"Rare complex mutational profile in an ALK inhibitor-resistant non-small cell lung cancer","volume":"35","author":"Azzato","year":"2015","journal-title":"Anticancer Res"},{"key":"key20260917101225_b18-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.lungcan.2016.01.002","article-title":"K-RAS mutations indicating primary resistance to crizotinib in ALK-rearranged adenocarcinomas of the lung: Report of two cases and review of the literature","volume":"93","author":"Mengoli","year":"2016","journal-title":"Lung Cancer"},{"key":"key20260917101225_b19-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.21037\/tcr.2019.06.23","article-title":"Dual drive coexistence of ALK rearrangement and KRAS mutation advanced lung adenocarcinoma and response to crizotinib","volume":"8","author":"Zhu","year":"2019","journal-title":"Transl Cancer Res"},{"key":"key20260917101225_b20-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.18632\/oncotarget.28062","article-title":"Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition","volume":"12","author":"Kemper","year":"2021","journal-title":"Oncotarget"},{"key":"key20260917101225_b21-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"1269148","DOI":"10.3389\/fonc.2024.1269148","article-title":"Case report: Successful treatment of advanced pulmonary sarcomatoid carcinoma with BUBIB-ALK rearrangement and KRAS G12C mutation by sintilimab combined with anlotinib","volume":"14","author":"Huang","year":"2024","journal-title":"Front Oncol"},{"key":"key20260917101225_b22-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.jmoldx.2025.08.008","article-title":"Analytical validation of a pan-cancer next-generation sequencing assay for in-house liquid biopsy testing: An international multicenter study","volume":"27","author":"Lescuyer","year":"2025","journal-title":"J Mol Diagn"},{"key":"key20260917101225_b23-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"12909","DOI":"10.1038\/s41598-023-39749-4","article-title":"Validation of the Idylla GeneFusion assay to detect fusions and MET exon-skipping in non-small cell lung cancers","volume":"13","author":"Gilson","year":"2023","journal-title":"Sci Rep"},{"key":"key20260917101225_b24-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"100337","DOI":"10.1016\/j.esmoop.2021.100337","article-title":"Real-world circulating tumor DNA analysis depicts resistance mechanism and clonal evolution in ALK inhibitor-treated lung adenocarcinoma patients","volume":"7","author":"Hua","year":"2022","journal-title":"ESMO Open"},{"key":"key20260917101225_b25-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.lungcan.2016.03.005","article-title":"EGFR, KRAS and ROS1 variants coexist in a lung adenocarcinoma patient","volume":"95","author":"Ju","year":"2016","journal-title":"Lung Cancer"},{"key":"key20260917101225_b26-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"e503","DOI":"10.1016\/j.cllc.2025.05.016","article-title":"Activity of brigatinib in patients with crizotinib-resistant ALK-positive non-small-cell lung cancer according to ALK fusion and mutation status","volume":"26","author":"Bazhenova","year":"2025","journal-title":"Clin Lung Cancer"},{"key":"key20260917101225_b27-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"e237107","DOI":"10.6004\/jnccn.2023.7107","article-title":"Response of a novel KANK1::ALK fusion to alectinib in an advanced lung adenocarcinoma: A case report","volume":"22","author":"Tang","year":"2024","journal-title":"J Natl Compr Canc Netw"},{"key":"key20260917101225_b28-ol-32-4-15803","doi-asserted-by":"publisher","first-page":"10041","DOI":"10.1007\/s00432-023-04924-7","article-title":"TP53 or CDKN2A\/B covariation in ALK\/RET\/ROS1-rearranged NSCLC is associated with a high TMB, tumor immunosuppressive microenvironment and poor prognosis","volume":"149","author":"Jiang","year":"2023","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:13:09Z","timestamp":1789629189000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15803"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8,5]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15803","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]}}}